Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality

BACKGROUND AND AIMS: Patients with severe coronavirus disease 2019 (COVID‐19) are at significant risk of thrombotic complications. However, their prothrombotic state is incompletely understood. Therefore, we measured in vivo activation markers of hemostasis, plasma levels of hemostatic proteins, and...

Descripción completa

Detalles Bibliográficos
Autores principales: von Meijenfeldt, Fien A., Havervall, Sebastian, Adelmeijer, Jelle, Lundström, Annika, Rudberg, Ann‐Sofie, Magnusson, Maria, Mackman, Nigel, Thalin, Charlotte, Lisman, Ton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles ‐ Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845083/
https://www.ncbi.nlm.nih.gov/pubmed/33537537
http://dx.doi.org/10.1002/rth2.12462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845083/
https://www.ncbi.nlm.nih.gov/pubmed/33537537
http://dx.doi.org/10.1002/rth2.12462

Ejemplares similares